Depth5000D translates to "Depth Development completes nearly $50 million in Series D financing" in English.

Recently, Beijing Depth Power Technology Co., Ltd., a provider of AI pharmaceutical research and development solutions, completed nearly $50 million in Series D financing, led by DHVC with participation from New Horizon Capital and Sequoia China. The funds will be used to accelerate the iteration of the Agent cluster technology and expand global cooperation with pharmaceutical companies. Depth Power was founded in 2018, focusing on providing full-stack intelligent solutions for pharmaceutical companies from pre-clinical to post-market. The company had previously received investment from Sequoia China, a well-known institution.